Novel Targeting of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Novel Targeting of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin in Renal Cell Carcinoma

Published:2013-07 Issue:4 Volume:19 Page:311-315
ISSN:1528-9117
Container-title:The Cancer Journal
language:en
Short-container-title:

Author:

Cho Daniel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference29 articles.

1. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.;Hudes;N Engl J Med,2007

2. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomized, placebo-controlled phase III trial.;Motzer;Lancet,2008

3. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.;Hsu;Science,2011

4. Tumour suppression by the human von Hippel-Lindau gene product.;Iliopoulos;Nat Med,1995

5. Role of transforming growth factor-alpha in von Hippel-Lindau (VHL) () clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.;de Paulsen;Proc Natl Acad Sci U S A,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFE3/PI3K/Akt/mTOR Axis in Renal Cell Carcinoma Affects Tumor Microenvironment;The American Journal of Pathology;2024-07

2. VHL Expression in Kidney Cancer: Relation to Metastasis Development, Transcription and Growth Factors and Component of Akt/m-TOR Signaling Pathway;Bulletin of Experimental Biology and Medicine;2019-09

3. Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review);Molecular Medicine Reports;2019-04-03

4. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy;International Journal of Molecular Sciences;2019-02-11

5. Preclinical evaluation of novel PI3K/mTOR dual inhibitor SN202 as potential anti-renal cancer agent;Cancer Biology & Therapy;2018-09-27